The effect of HMG-CoA reductase inhibitor on glucose tolerance and insulin sensitivity in type 2 diabetes mellitus animal model

被引：0
|
作者：
Kwon, Hyuk-Sang
Hong, Oak-Kee
Ko, Seung-Hyun
Choi, Yoon-Hee
Lee, Sung-Soo
Son, Tae-Seo
Moon, Sung-Dae
Yoo, Soon-Jib
Son, Hyun-Sik
Yoon, Kun-Ho
Cha, Bong-Yun
Son, Ho-Young
机构：
来源：
DIABETES | 2006年 / 55卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：A565 / A565
页数：1
相关论文
共 50 条
  • [41] Risk Factor for Diabetes Mellitus and High Blood Glucose With HMG-CoA Reductase Inhibitors Using a Postmarketing Surveillance Database in Japan
    Hashiguchi, Masayuki
    Maruyama, Junya
    Shimizu, Mikiko
    Takahashi, Daichi
    Shiga, Tsuyoshi
    CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT, 2018, 7 (08): : 800 - 810
  • [42] Biphasic effect of HMG-CoA reductase inhibitor, pitavastatin, on vascular endothelial cells and angiogenesis
    Katsumoto, M
    Shingu, T
    Kuwashima, R
    Nakata, A
    Nomura, S
    Chayama, K
    CIRCULATION JOURNAL, 2005, 69 (12) : 1547 - 1555
  • [43] The HMG-CoA reductase inhibitor lovastatin reverses the learning and attention deficits in a mouse model of neurofibromatosis type 1
    Li, WD
    Cui, YJ
    Kushner, SA
    Brown, RAM
    Jentsch, JD
    Frankland, PW
    Cannon, TD
    Silva, AJ
    CURRENT BIOLOGY, 2005, 15 (21) : 1961 - 1967
  • [44] Mechanisms underlying recoupling of eNOS by HMG-CoA reductase inhibition in a rat model of streptozotocin-induced diabetes mellitus
    Wenzel, Philip
    Daiber, Andreas
    Oelze, Matthias
    Brandt, Moritz
    Closs, Ellen
    Xu, Jian
    Thum, Thomas
    Bauersachs, Johann
    Ertl, Georg
    Zou, Ming-Hui
    Foerstermann, Ulrich
    Muenzel, Thomas
    ATHEROSCLEROSIS, 2008, 198 (01) : 65 - 76
  • [45] Systemic administration of HMG-CoA reductase inhibitor protects the blood-retinal barrier and ameliorates retinal inflammation in type 2 diabetes
    Li, Jingming
    Wang, Joshua J.
    Chen, Danyang
    Mott, Robert
    Yu, Qiang
    Ma, Jian-xing
    Zhang, Sarah X.
    EXPERIMENTAL EYE RESEARCH, 2009, 89 (01) : 71 - 78
  • [46] Combination treatment with an insulin action enhancer and an inhibitor of HMG-CoA reductase shows a synergistic effect on atherosclerosis of WHHL rabbits
    Shiomi, M
    Ito, T
    Tsukada, T
    Tsujita, Y
    Horikoshi, H
    LIPOPROTEIN METABOLISM AND ATHEROGENESIS, 2000, : 224 - 226
  • [47] Tolerance and pharmacokinetics of single-dose atorvastatin, a potent inhibitor of HMG-CoA reductase, in healthy subjects
    Posvar, EL
    Radulovic, LL
    Cilla, DD
    Whitfield, LR
    Sedman, AJ
    JOURNAL OF CLINICAL PHARMACOLOGY, 1996, 36 (08): : 728 - 731
  • [48] Anti-lipid deposition effect of HMG-CoA reductase inhibitor, pitavastatin, in a rat model of hypertension and hypercholesterolemia
    Kumai, T
    Oonuma, S
    Matsumoto, N
    Takeba, Y
    Taniguchi, R
    Kamio, K
    Miyazu, O
    Koitabashi, Y
    Sekine, S
    Tadokoro, M
    Kobayashi, S
    LIFE SCIENCES, 2004, 74 (17) : 2129 - 2142
  • [49] HMG-CoA reductase inhibitor, simvastatin improves reverse cholesterol transport in type 2 diabetic patients with hyperlipidemia
    Guan, Jing-Zhi
    Tamasawa, Naoki
    Murakami, Hiroshi
    Matsui, Jun
    Tanabe, Jutaro
    Matsuki, Kota
    Yamashita, Maki
    Suda, Toshihiro
    JOURNAL OF ATHEROSCLEROSIS AND THROMBOSIS, 2008, 15 (01) : 20 - 25
  • [50] The HMG-CoA Reductase Inhibitor Pravastatin Stimulates Insulin Secretion through Organic Anion Transporter Polypeptides
    Abe, Michiaki
    Toyohara, Takafumi
    Ishii, Akiko
    Suzuki, Takehiro
    Noguchi, Naoya
    Akiyama, Yasutoshi
    Shiwaku, Hiromi O.
    Nakagomi-Hagihara, Rie
    Zheng, Guodong
    Shibata, Eisuke
    Souma, Tomokazu
    Shindo, Tomohiko
    Shima, Hirohito
    Takeuchi, Yoichi
    Mishima, Eikan
    Tanemoto, Masayuki
    Terasaki, Tetsuya
    Onogawa, Tohru
    Unno, Michiaki
    Ito, Sadayoshi
    Takasawa, Shin
    Abe, Takaaki
    DRUG METABOLISM AND PHARMACOKINETICS, 2010, 25 (03) : 274 - 282
12345